Current Updates and Progress Reports of the BC CfE Per-SVR Study


Click on image to read newsletter in larger format.

image of newsletter from PrEseRvation of Sustained Virological Response study. Click on image and full text of pdf will open in new window.

What’s Per-SVR?

Per-SVR is part of the development of Treatment as Prevention® for HCV strategy in British Columbia.

Per-SVR (PrEseRvation of Sustained Virological Response) is a longitudinal cohort study following people who have been successfully treated for HCV using Direct-Acting Antivirals (DAAs). Clients are eligible if they are 19 years of age or older, have an undetectable viral load at the end of HCV treatment, reside in British Columbia, a currently on HCV treatment or have completed treatment in the last three months.

Participation in the study will include 10 visits (four in the first year, and two per year for the remaining three years). Each visit will consist of an interview led by our researchers as well as blood (HCV RNA, Liver Function & HIV) and urine. Clients receive an honorarium of $40 at the end of each visit and are connected back to their referring clinic if HCV/HIV is detected.

Recruitment is ongoing for Per-SVR. If you know anyone that could be eligible please reach out to us at 604-416-1566! Read this latest newsletter to learn more.